Terns Pharmaceuticals Announces Leadership Transition
Mr. Sundaram also resigned from the Board of Directors of Terns but will remain on as a Senior Advisor to the Company.
- Mr. Sundaram also resigned from the Board of Directors of Terns but will remain on as a Senior Advisor to the Company.
- Erin Quirk, M.D., President and Head of Research & Development at Terns, will assume leadership of the Company, effective immediately.
- “On behalf of the entire Board, I extend our gratitude to Sen for his many contributions to Terns during his CEO tenure.
- We wish all the best for Sen and his family and will always consider him a member of the Terns team,” said David Fellows, Chairman of the Board of Terns.